Elizabeth E. Reed, SVP, GC & CORPORATE SECRETARY at Travere Therapeutics, Inc. (TVTX), sold 8,774 shares at $11.52 ($101K) on 2024-09-09, disclosed to the SEC on 2024-09-09.
Scheduled sale ($101k) by SVP, GC & CORPORATE SECRETARY under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.52 | 4,387 | $51K | 50.0% |
| 2 | $11.52 | 4,387 | $51K | 50.0% |
| Total | $11.52 avg | 8,774 | $101K | 100% |
| Filing → |
| TVTX | SELL | 2026-04-15 | $2.1M | — | Filing → |
| TVTX | SELL | 2026-04-02 | $300K | — | Filing → |
| TVTX | SELL | 2026-03-18 | $562K | — | Filing → |